Literature DB >> 11073773

An outbreak of Staphylococcus aureus strains with reduced susceptibility to glycopeptides in a French general hospital.

P Pina1, C Marliere, F Vandenesch, J P Bedos, J Etienne, P Y Allouch.   

Abstract

We describe the isolation of Staphylococcus aureus isolates with glycopeptide heteroresistant subpopulation from 15 patients (11 with colonizations and 4 with infections) in a French hospital. Non of the patients were previously treated with glycopeptides. The 15 isolates belonged to 2 different pulsotypes unrelated to other methicillin-resistant S. aureus isolates from the same hospital.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11073773     DOI: 10.1086/317464

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  5 in total

1.  First report of vancomycin-resistant staphylococci isolated from healthy carriers in Brazil.

Authors:  I C V Palazzo; M L C Araujo; A L C Darini
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

Review 2.  New developments in antibacterial choice for lower respiratory tract infections in elderly patients.

Authors:  Anna Maria Ferrara; Anna Maria Fietta
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

Review 3.  Vancomycin resistance in staphylococci.

Authors:  Arjun Srinivasan; James D Dick; Trish M Perl
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

Review 4.  Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications.

Authors:  Benjamin P Howden; John K Davies; Paul D R Johnson; Timothy P Stinear; M Lindsay Grayson
Journal:  Clin Microbiol Rev       Date:  2010-01       Impact factor: 26.132

5.  Daptomycin Resistance in Clinical MRSA Strains Is Associated with a High Biological Fitness Cost.

Authors:  Melanie Roch; Paula Gagetti; James Davis; Paola Ceriana; Laura Errecalde; Alejandra Corso; Adriana E Rosato
Journal:  Front Microbiol       Date:  2017-12-05       Impact factor: 5.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.